Deep Science Ventures Becomes Latest Partner of One Nucleus

Cambridge and London, UK: 14 September 2021

One Nucleus, the non-for-profit Life Science membership group focused primarily on the Greater Cambridge and London Life Sciences Cluster aims to enable that ecosystem to accelerate the translation of great science and innovation into better patient outcomes. Supporting companies throughout their life cycle. This includes facilitating connections between entrepreneurs and company-makers, including investors. Deep Science Ventures (DSV) operate across multiple sectors combining world-leading knowledge, talent and investment to form high impact new ventures. DSV have now become the become the latest company to join the One Nucleus Partner Programme. The programme is tailor-made to meet the needs of the Partner, One Nucleus members and the sector as a whole.

Kirsten Papenfuss, Associate Director (Pharma) at DSV commented, “Joining the One Nucleus Partner Programme enables us to bring our unique approach to innovation and resultant new ventures closer to this wider and globally connected ecosystem. DSV is committed to creating and investing in early-stage companies whose technology has true potential to transform patient outcomes. We have a collaborative approach, supporting the next generation of science entrepreneurs along their journey and this collaboration brings further opportunities for DSV to contribute to the ecosystem and support our portfolio companies.”

Tony Jones, CEO of One Nucleus expands further “We are extremely pleased to welcome DSV to the One Nucleus Partner Programme given their novel approach across sectors that increasingly converge in the field of life sciences and healthcare. Their impressive track record of founding and accelerating the growth innovative companies speaks for itself. I feel engaging in this strategic manner will bring value to them, their portfolio companies and One Nucleus membership where intellectual engagement and collaboration are key. DSV bring impressive expertise, connectivity and capacity to help us in our activity to support our network in changing lives for the better.”

Media Contact Information: 

Tony Jones, CEO
Email: Tony@onenucleus.com

Tel: +44 (0)1223 896463

Web:  www.onenucleus.com